Beacon Harbor Wealth Advisors, Inc. Gilead Sciences, Inc. Transaction History

Beacon Harbor Wealth Advisors, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $116,206 - $131,780	1,586 Added 2.28%	71,133 $5.76 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $89,615 - $97,772	1,212 Added 1.77%	69,547 $5.21 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $5.19 Million - $5.92 Million	68,335 New	68,335 $5.27 Million
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $3.75 Million - $4.7 Million	-64,728 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $10,705 - $12,150	-165 Reduced 0.25%	64,728 $4.7 Million
Q3 2021 Oct 29, 2021	BUY	$67.69 - $73.03 $90,907 - $98,079	1,343 Added 2.11%	64,893 $4.53 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $330,044 - $360,619	5,200 Added 8.91%	63,550 $4.38 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $381,420 - $435,200	6,357 Added 12.23%	58,350 $3.77 Million
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $221,274 - $252,132	3,906 Added 8.12%	51,993 $3.03 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $290,193 - $364,867	-4,673 Reduced 8.86%	48,087 $3.04 Million
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $232,211 - $269,640	3,210 Added 6.48%	52,760 $4.06 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $1.1 Million - $1.41 Million	17,579 Added 54.98%	49,550 $3.7 Million
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $31,980 - $35,177	519 Added 1.65%	31,971 $2.08 Million
Q3 2019 Oct 17, 2019	BUY	$62.51 - $69.0 $102,891 - $113,574	1,646 Added 5.52%	31,452 $2.05 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $1.84 Million - $2.07 Million	29,806 New	29,806 $2.01 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Beacon Harbor Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Harbor Wealth Advisors, Inc. with notifications on news.